{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T01:36:22Z","timestamp":1715996182298},"reference-count":18,"publisher":"Elsevier BV","issue":"6","content-domain":{"domain":["mdconsult.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.hlc.2013.11.012","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T20:31:03Z","timestamp":1386793863000},"page":"e149-e151","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Interaction of Terbinafine (Anti-fungal agent) with Perhexiline: A Case Report"],"prefix":"10.1016","volume":"23","author":[{"given":"Abdul Rauf","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Westley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Sallustio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F","family":"Beltrame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.hlc.2013.11.012_bib0005","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5694\/j.1326-5377.1976.tb140585.x","article-title":"A double blind trial of perhexiline maleate in the prophylaxis of angina pectoris","volume":"1","author":"Brown","year":"1976","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.hlc.2013.11.012_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1445-5994.1997.tb00909.x","article-title":"Perhexiline improves symptomatic status in elderly patients with severe aortic stenosis","volume":"27","author":"Unger","year":"1997","journal-title":"Aust N Z J Med"},{"issue":"9","key":"10.1016\/j.hlc.2013.11.012_bib0015","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/eurjhf\/hfp106","article-title":"Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hope","volume":"11","author":"Phan","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.hlc.2013.11.012_bib0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2165\/00129784-200101030-00005","article-title":"Systematic review of the efficacy and safety of perhexiline in the treatment of ischemic heart disease","volume":"1","author":"Sheila","year":"2001","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.hlc.2013.11.012_bib0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0167-5273(86)90146-4","article-title":"Perhexiline maleate treatment for severe angina pectoris correlation with phannacokinetics","volume":"13","author":"Horowitz","year":"1986","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.hlc.2013.11.012_bib0030","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/01.CIR.81.4.1260","article-title":"Efficacy and safety of perhexiline maleate in refractory angina","volume":"81","author":"Cole","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2013.11.012_bib0035","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/00048679709065084","article-title":"Interaction of serotonin re-uptake inhibitors with perhexiline","volume":"31","author":"Alderman","year":"1997","journal-title":"Aust N Z J Psychiatry"},{"issue":"No. 4","key":"10.1016\/j.hlc.2013.11.012_bib0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/jppr1998284254","article-title":"Perhexiline-paroxetine drug interaction","volume":"Vol. 28","author":"Alderman","year":"1998","journal-title":"Australian Journal of Hospital Pharmacy"},{"issue":"4","key":"10.1016\/j.hlc.2013.11.012_bib0045","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4306\/pi.2012.9.4.422","article-title":"Prolonged Drug-Drug Interaction between Terbinafine and Perphenazine","volume":"9","author":"Young-Min","year":"2012","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.hlc.2013.11.012_bib0050","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/01.ftd.0000175910.68539.33","article-title":"Prolonged pharmacokinetic drug interaction between terbinafine and amitriptyline","volume":"27","author":"Castberg","year":"2005","journal-title":"Ther Drug Monit"},{"issue":"4","key":"10.1016\/j.hlc.2013.11.012_bib0055","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1365-2125.2003.02033.x","article-title":"Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexiline","volume":"57","author":"Davies","year":"2004","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.hlc.2013.11.012_bib0060","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/01.ftd.0000175910.68539.33","article-title":"Prolonged pharmacokinetic drug interaction between terbinafine and amitriptyline","volume":"27","author":"Castberg","year":"2005","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.hlc.2013.11.012_bib0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/000155557300304","article-title":"Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250mg terbinafine orally once per day or four weeks","volume":"73","author":"Faergemann","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.hlc.2013.11.012_bib0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF03258479","article-title":"Elimination kinetics of terbinafine from human plasma and tissues following multiple dose administration and comparison with 3 main metabolites","volume":"8","author":"Zehender","year":"1994","journal-title":"Drug Invest"},{"key":"10.1016\/j.hlc.2013.11.012_bib0075","first-page":"2738","volume":"39","author":"Kovarik","year":"1995","journal-title":"Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites. Antimicrob Agents Chemother"},{"key":"10.1016\/j.hlc.2013.11.012_bib0080","author":"Flockhart","year":"2007","journal-title":"Drug Interactions Cytochrome P450 Drug Interaction Table. Indiana University School of Medicine;"},{"issue":"6","key":"10.1016\/j.hlc.2013.11.012_bib0085","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1124\/dmd.31.6.768","article-title":"Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes p450 in vitro","volume":"31","author":"Zhang","year":"2003","journal-title":"Drug Metab. Dispos"},{"issue":"11","key":"10.1016\/j.hlc.2013.11.012_bib0090","doi-asserted-by":"crossref","first-page":"560","DOI":"10.5694\/j.1326-5377.2002.tb04558.x","article-title":"Perhexiline toxicity related to citalopram use","volume":"176","author":"Nyfort-Hansen","year":"2002","journal-title":"Med J Aus."}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950613013607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950613013607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T22:44:20Z","timestamp":1688856260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950613013607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1443950613013607"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2013.11.012","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interaction of Terbinafine (Anti-fungal agent) with Perhexiline: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2013.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2013 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}